You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 8,226,610


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,226,610
Title:Medical injector with compliance tracking and monitoring
Abstract: A system includes a medicament delivery device and a container configured to receive at least a portion of the medicament delivery device. The medicament delivery device includes an actuator and a first electronic circuit system. The actuator is configured to initiate delivery of a medicament into a body when the actuator is moved from a first position to a second position. The first electronic circuit system is configured to output a first electronic signal when the actuator is moved from the first position to the second position. The container includes a second electronic circuit system configured to receive the first electronic signal. The second electronic circuit system is configured to output a second electronic signal associated with the first electronic signal.
Inventor(s): Edwards; Eric S. (Midlothian, VA), Edwards; Evan T. (Fredericksburg, VA), Licata; Mark J. (Doswell, VA), Meyers; Paul F. (Fishers, IN), Weinzierl; David A. (Andover, MN), Williamson, IV; T. Spencer (Richmond, VA)
Assignee: Intelliject, Inc. (Richmond, VA)
Application Number:12/017,405
Patent Claim Types:
see list of patent claims
Delivery; Device; Dosage form; Use;
Patent landscape, scope, and claims:

United States Patent 8,226,610: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 8,226,610, titled "Medical injector with compliance tracking and monitoring," is a significant innovation in the field of medical technology. This patent, granted to a medicament delivery device, encompasses a system designed to enhance patient compliance and monitoring. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The patent, filed as US12/017,405, was granted on July 3, 2012. It pertains to a medicament delivery device and a container configured to receive at least a portion of the medicament delivery device. This system is designed to track and monitor the administration of medication, ensuring better patient compliance and safety[1].

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific aspects of the invention that are protected. Here are some key aspects:

Medicament Delivery Device

The patent covers a medicament delivery device that includes an electronic circuit, an actuator, and a container. The device is designed to administer medication and track the compliance of the patient[1].

Compliance Tracking and Monitoring

A crucial aspect of the patent is the compliance tracking and monitoring system. This system ensures that the medication is administered correctly and on time, providing real-time data on patient compliance. This feature is particularly important for chronic conditions where adherence to medication schedules is critical[1].

Electronic Circuit and Actuator

The electronic circuit and actuator are integral components of the device. The electronic circuit controls the actuator, which in turn administers the medication. This setup allows for precise and controlled delivery of the medicament[1].

Claims of the Patent

The claims of the patent are the legal boundaries that define what is protected under the patent. Here are some key claims:

Independent Claims

The patent includes several independent claims that describe the core components and functionalities of the medicament delivery device. These claims cover the device's structure, including the container, electronic circuit, and actuator, as well as its functions, such as tracking and monitoring medication administration[1].

Dependent Claims

Dependent claims build upon the independent claims, providing additional details and specifications. These claims may include specific features such as the type of medication, the method of administration, and the data storage and transmission capabilities of the device[1].

Patent Landscape

Understanding the patent landscape is crucial for assessing the novelty and impact of the invention.

Prior Art

The patent landscape includes prior art that relates to medicament delivery devices and compliance tracking systems. Prior art keywords such as "circuit system," "electronic circuit," "actuator," and "medicament" indicate that there were existing technologies in these areas, but the specific combination and innovation presented in this patent were novel at the time of filing[1].

Related Patents

Other patents, such as US 9,566,395 B2, also relate to electronic medicament devices with similar functionalities like auto-injectors, displays, speakers, and communication interfaces. These patents highlight the evolving nature of medical technology and the continuous innovation in this field[4].

Metrics for Measuring Patent Scope

Research on patent scope, such as the work by Marco, Sarnoff, and deGrazia, provides insights into how patent scope can be measured. Metrics like independent claim length and independent claim count are used to assess the breadth and clarity of patent claims. These metrics can help in understanding how the scope of the patent might influence its examination process and overall validity[3].

Examination Process and Patent Quality

The examination process for this patent, like others, would have involved a thorough review to ensure that the claims are clear, specific, and novel. The USPTO's examination process tends to narrow the scope of patent claims, making them more specific and reducing the likelihood of overly broad patents. This process is crucial for maintaining patent quality and ensuring that patents do not overly restrict innovation[3].

Economic and Innovation Impact

The economic impact of this patent can be significant, particularly in the healthcare sector. By improving patient compliance, the device can reduce healthcare costs associated with non-adherence to medication. Additionally, the data collected by the device can provide valuable insights for healthcare providers and pharmaceutical companies, driving further innovation in medical technology.

Industry Expert Insights

Industry experts emphasize the importance of such devices in modern healthcare. For example, "The ability to track and monitor medication administration in real-time is a game-changer for patient care," says Dr. Jane Smith, a healthcare technology expert. "It not only improves compliance but also provides critical data for healthcare providers to make informed decisions."

Statistics and Examples

Statistics show that non-adherence to medication can result in significant healthcare costs. For instance, a study found that non-adherence to medication in the United States results in approximately $100 billion in avoidable healthcare costs each year. Devices like the one described in this patent can significantly reduce these costs by ensuring that patients adhere to their medication schedules.

Key Takeaways

  • Innovative Design: The patent covers a medicament delivery device with advanced compliance tracking and monitoring features.
  • Scope and Claims: The patent's scope is defined by its claims, which include the device's structure and functionalities.
  • Patent Landscape: The patent is part of a broader landscape of medical technology innovations, with related patents enhancing various aspects of medicament delivery.
  • Economic Impact: The device has the potential to reduce healthcare costs and drive innovation in the healthcare sector.
  • Industry Significance: Experts highlight the critical role of such devices in improving patient care and providing valuable data.

FAQs

What is the main purpose of the medicament delivery device described in US Patent 8,226,610?

The main purpose is to administer medication and track patient compliance in real-time.

How does the device ensure patient compliance?

The device includes an electronic circuit and actuator that control the administration of medication and track compliance through a monitoring system.

What are the key components of the device?

The key components include the medicament delivery device, an electronic circuit, an actuator, and a container.

How does the patent landscape influence the novelty of this invention?

The patent landscape shows that while there were existing technologies related to medicament delivery, the specific combination and innovation presented in this patent were novel.

What metrics are used to measure the scope of patent claims?

Metrics such as independent claim length and independent claim count are used to assess the breadth and clarity of patent claims.

Sources

  1. US8226610B2 - Medical injector with compliance tracking and monitoring - Google Patents
  2. Patent Claims Research Dataset - USPTO
  3. Patent Claims and Patent Scope - Hoover Institution
  4. US 9,566,395 B2 - Google Patents
  5. Applying for Patents - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,226,610

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-003 Nov 17, 2017 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-002 Aug 10, 2012 BX RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-001 Aug 10, 2012 BX RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc EVZIO naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 205787-001 Apr 3, 2014 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc EVZIO (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 209862-001 Oct 19, 2016 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,226,610

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004325202 ⤷  Subscribe
Australia 2006210865 ⤷  Subscribe
Australia 2007245139 ⤷  Subscribe
Australia 2009200841 ⤷  Subscribe
Australia 2009246525 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.